Home Insulet Corporation

Insulet Corporation

Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions

Omnipod 5 Automated Glucose Control System, Powered by Horizon™ (Omnipod 5), formerly known as the Omnipod Horizon System, is the first tubeless smartphone-controlled automated insulin delivery system for people living with diabetes.

Insulet Resumes Pivotal Study of its Next-Generation Product – Omnipod, Powered by Horizon™

Insulet expects to commercialize Omnipod, Powered by Horizon, in the U.S. in the first half of 2021, pending clearance by the FDA.

Omnipod® Insulin Management System Now Available for Use in Europe with Fiasp® Fast-Acting Insulin

10/2/18: Novo Nordisk’s Fiasp® (Fast-Acting Insulin Aspart) has been tested and found safe for use in Insulet’s Omnipod System in Europe.

Insulet to Preview New Clinical Data and Next Generation Omnipod® System at the American Diabetes Association’s 77th Scientific Sessions

Insulet will exhibit at this year’s Scientific Session at Booth Location 507 and have four poster presentations...

Insulet Corporation to Announce First Quarter 2017 Financial Results

To Be Announced May 8, 2017 Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless...